in the United States domestic and global supply chain to combat a global pandemic due to reliance on Chinese manufacturing and recommendations for decreasing dependence on Chinese manufacturing by improving and securing a domestic supply chain for antibiotics, viral drugs, critical pharmaceutical components, masks, and other personal protective equipment. (10) Information related to lessons learned from China’s handling of such coronavirus. (11) Any other relevant issues relating to China’s actions that led to further spread of such coronavirus, China’s response to such coronavirus, or the investigation by the Joint Select Committee into China regarding such coronavirus. (12) Any recommendations to Congress and the executive branch regarding actions the United States government should take in response to China’s handling of such coronavirus. (b) Transfer of records At the request of the co-chairs of the Joint Select Committee, any standing committee of the Senate or House of Representatives having custody of records in any form relating to the matters described in subsection (a) shall transfer such records to the Joint Select Committee. (c) Interim reports In addition to the final report issued under subsection (a), the Joint Select Committee may issue such interim reports as it considers necessary. (d) Classified annex The Joint Select Committee may include a classified annex in any report issued under this section. (e) Definitions (1) China In this section, the term China means the Government of the People’s Republic of China and any of the following: (A) An official of the Chinese Communist Party. (B) An official of the Government of the People’s Republic of China. (C) An agent or instrumentality of the Government of the People’s Republic of China. (D) Any other person owned or controlled by or acting on behalf of any person described in subparagraphs (A) through (C). (2) 2019 novel coronavirus In this subsection, the term 2019 novel coronavirus means the coronavirus disease (COVID–19) and severe acute